Hans J. Schmoll
Halle, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 25, 2025
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Journal: Leukemia
Published: January 12, 2022
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.
Journal: The Lancet. Haematology
Published: May 14, 2017
Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.
Journal: International journal of cancer
Published: May 22, 2016
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Journal: The Lancet. Haematology
Published: February 11, 2016
A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer.
Journal: Journal of the National Cancer Institute
Published: October 09, 2014
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 17, 2014
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 14, 2013
EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 26, 2013
Review of the efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in a range of tumor types.
Journal: Cancer treatment reviews
Published: July 13, 2012
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature.
Journal: European urology
Published: February 12, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026